KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Gilead Sciences (GILD) over the last 16 years, with Q4 2024 value amounting to $21.8 million.

  • Gilead Sciences' Treasury Shares fell 396.48% to $21.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $21.8 million, marking a year-over-year decrease of 396.48%. This contributed to the annual value of $21.8 million for FY2024, which is 396.48% down from last year.
  • Latest data reveals that Gilead Sciences reported Treasury Shares of $21.8 million as of Q4 2024, which was down 396.48% from $11.0 million recorded in Q3 2024.
  • In the past 5 years, Gilead Sciences' Treasury Shares ranged from a high of $25.0 million in Q3 2020 and a low of $5.0 million during Q1 2023
  • For the 5-year period, Gilead Sciences' Treasury Shares averaged around $12.7 million, with its median value being $10.0 million (2021).
  • Per our database at Business Quant, Gilead Sciences' Treasury Shares tumbled by 7000.0% in 2021 and then surged by 13750.0% in 2022.
  • Quarter analysis of 5 years shows Gilead Sciences' Treasury Shares stood at $25.0 million in 2020, then plummeted by 68.0% to $8.0 million in 2021, then surged by 137.5% to $19.0 million in 2022, then rose by 19.47% to $22.7 million in 2023, then dropped by 3.96% to $21.8 million in 2024.
  • Its Treasury Shares stands at $21.8 million for Q4 2024, versus $11.0 million for Q3 2024 and $7.0 million for Q2 2024.